Cheplapharm AG, an international platform for branded medicines, has announced raising €550 million (about $543 million) in structured investment from Singapore sovereign wealth fund GIC and Atlantic Park.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
